Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
beta-Lactamases | 6 | 2021 | 307 | 1.240 |
Why?
|
Growth Differentiation Factor 2 | 4 | 2020 | 27 | 0.880 |
Why?
|
MicroRNAs | 10 | 2021 | 3796 | 0.800 |
Why?
|
Aztreonam | 2 | 2021 | 10 | 0.780 |
Why?
|
Enterobacteriaceae Infections | 3 | 2020 | 194 | 0.780 |
Why?
|
Fusion Proteins, bcr-abl | 6 | 2013 | 431 | 0.750 |
Why?
|
Osteogenesis | 5 | 2020 | 1273 | 0.660 |
Why?
|
Cross Infection | 4 | 2020 | 1438 | 0.530 |
Why?
|
Bacterial Proteins | 5 | 2020 | 3847 | 0.510 |
Why?
|
Mesenchymal Stem Cells | 5 | 2020 | 1642 | 0.510 |
Why?
|
Cell Proliferation | 15 | 2019 | 10431 | 0.460 |
Why?
|
Azabicyclo Compounds | 2 | 2021 | 68 | 0.460 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 | 2011 | 685 | 0.450 |
Why?
|
Aminoglycosides | 2 | 2014 | 163 | 0.420 |
Why?
|
Recombinases | 1 | 2023 | 67 | 0.420 |
Why?
|
Hepatitis B, Chronic | 3 | 2012 | 410 | 0.420 |
Why?
|
Enterobacter cloacae | 2 | 2012 | 22 | 0.420 |
Why?
|
Stomach Neoplasms | 3 | 2019 | 1432 | 0.410 |
Why?
|
beta-Lactam Resistance | 2 | 2012 | 75 | 0.410 |
Why?
|
Auranofin | 1 | 2021 | 16 | 0.400 |
Why?
|
Carcinoma, Hepatocellular | 5 | 2017 | 2299 | 0.390 |
Why?
|
Liver Diseases | 3 | 2021 | 1296 | 0.380 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2021 | 18 | 0.370 |
Why?
|
Ceftazidime | 1 | 2021 | 57 | 0.370 |
Why?
|
Microbial Sensitivity Tests | 6 | 2024 | 1956 | 0.370 |
Why?
|
Liver Circulation | 1 | 2010 | 159 | 0.360 |
Why?
|
Aluminum Silicates | 1 | 2020 | 24 | 0.350 |
Why?
|
Receptors, Notch | 2 | 2019 | 743 | 0.350 |
Why?
|
Ligation | 2 | 2011 | 448 | 0.350 |
Why?
|
Bronchi | 2 | 2016 | 845 | 0.350 |
Why?
|
Quinolones | 2 | 2014 | 378 | 0.350 |
Why?
|
Cranial Sutures | 1 | 2020 | 92 | 0.340 |
Why?
|
Antifungal Agents | 2 | 2024 | 752 | 0.330 |
Why?
|
Aluminum | 1 | 2020 | 152 | 0.330 |
Why?
|
Monensin | 1 | 2018 | 30 | 0.330 |
Why?
|
Escherichia coli O157 | 1 | 2018 | 53 | 0.320 |
Why?
|
Liver Neoplasms | 5 | 2017 | 4321 | 0.310 |
Why?
|
Plant Extracts | 2 | 2016 | 497 | 0.310 |
Why?
|
Bacteriological Techniques | 1 | 2019 | 279 | 0.310 |
Why?
|
Lymphocyte Antigen 96 | 1 | 2017 | 21 | 0.300 |
Why?
|
Centrosome | 2 | 2009 | 209 | 0.290 |
Why?
|
Carbapenems | 3 | 2012 | 125 | 0.290 |
Why?
|
Sulfhydryl Compounds | 1 | 2018 | 298 | 0.280 |
Why?
|
Recombinant Fusion Proteins | 4 | 2013 | 3734 | 0.280 |
Why?
|
Anti-Bacterial Agents | 5 | 2021 | 7439 | 0.280 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2021 | 589 | 0.270 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2019 | 8527 | 0.270 |
Why?
|
alpha-Fetoproteins | 1 | 2017 | 223 | 0.270 |
Why?
|
Living Donors | 1 | 2010 | 641 | 0.260 |
Why?
|
K562 Cells | 7 | 2013 | 642 | 0.260 |
Why?
|
Flavonols | 1 | 2016 | 85 | 0.260 |
Why?
|
Rectum | 1 | 2020 | 892 | 0.250 |
Why?
|
Craniosynostoses | 1 | 2020 | 412 | 0.250 |
Why?
|
Hospitals, Teaching | 3 | 2024 | 1156 | 0.250 |
Why?
|
Cytoplasm | 3 | 2011 | 1511 | 0.250 |
Why?
|
Angiotensin II | 1 | 2018 | 849 | 0.250 |
Why?
|
Osteopontin | 1 | 2017 | 301 | 0.250 |
Why?
|
Candidiasis, Invasive | 1 | 2015 | 23 | 0.250 |
Why?
|
Adenoviridae | 4 | 2014 | 1084 | 0.240 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 749 | 0.230 |
Why?
|
Apoptosis | 9 | 2018 | 9474 | 0.230 |
Why?
|
Drug Resistance, Fungal | 1 | 2024 | 75 | 0.230 |
Why?
|
Hepatitis B virus | 3 | 2014 | 529 | 0.230 |
Why?
|
Toll-Like Receptor 4 | 1 | 2017 | 579 | 0.230 |
Why?
|
Cholestasis | 2 | 2013 | 378 | 0.230 |
Why?
|
Down-Regulation | 3 | 2019 | 2913 | 0.230 |
Why?
|
Meningitis, Cryptococcal | 1 | 2024 | 67 | 0.230 |
Why?
|
Candida | 1 | 2015 | 173 | 0.230 |
Why?
|
Growth Differentiation Factors | 2 | 2019 | 99 | 0.220 |
Why?
|
Fluconazole | 1 | 2024 | 157 | 0.220 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.220 |
Why?
|
Trans-Activators | 2 | 2014 | 2858 | 0.220 |
Why?
|
Wnt1 Protein | 1 | 2014 | 120 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Interleukin-8 | 1 | 2016 | 696 | 0.220 |
Why?
|
Cryptococcus neoformans | 1 | 2024 | 121 | 0.220 |
Why?
|
Water | 1 | 2020 | 1410 | 0.220 |
Why?
|
Viral Core Proteins | 1 | 2014 | 161 | 0.220 |
Why?
|
Methanol | 2 | 2019 | 92 | 0.220 |
Why?
|
Cell-Penetrating Peptides | 1 | 2013 | 49 | 0.220 |
Why?
|
Hydrogels | 1 | 2019 | 721 | 0.220 |
Why?
|
Transfection | 7 | 2019 | 5776 | 0.210 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.210 |
Why?
|
China | 6 | 2024 | 2348 | 0.210 |
Why?
|
Oncogenes | 1 | 2019 | 1223 | 0.210 |
Why?
|
Cell Cycle | 5 | 2018 | 2930 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 200 | 0.210 |
Why?
|
Acinetobacter Infections | 1 | 2012 | 73 | 0.200 |
Why?
|
Epithelial Cells | 2 | 2016 | 3666 | 0.200 |
Why?
|
Tissue Scaffolds | 1 | 2019 | 936 | 0.200 |
Why?
|
Cholestasis, Extrahepatic | 1 | 2011 | 52 | 0.200 |
Why?
|
Cell Differentiation | 7 | 2024 | 11531 | 0.200 |
Why?
|
HEK293 Cells | 6 | 2020 | 4280 | 0.200 |
Why?
|
Acinetobacter baumannii | 1 | 2012 | 118 | 0.190 |
Why?
|
Bile Duct Diseases | 1 | 2011 | 97 | 0.190 |
Why?
|
Coffee | 1 | 2016 | 593 | 0.190 |
Why?
|
GRB2 Adaptor Protein | 1 | 2011 | 101 | 0.190 |
Why?
|
Fibrosis | 1 | 2018 | 2048 | 0.190 |
Why?
|
Interleukin-17 | 1 | 2016 | 911 | 0.180 |
Why?
|
HSP110 Heat-Shock Proteins | 1 | 2010 | 10 | 0.180 |
Why?
|
Estrogen Receptor alpha | 1 | 2014 | 581 | 0.180 |
Why?
|
eIF-2 Kinase | 1 | 2011 | 145 | 0.180 |
Why?
|
Escherichia coli Infections | 1 | 2014 | 523 | 0.180 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1459 | 0.180 |
Why?
|
Hepatitis B Antibodies | 1 | 2011 | 160 | 0.180 |
Why?
|
Carcinoma | 1 | 2022 | 2328 | 0.180 |
Why?
|
Chemokine CXCL10 | 1 | 2011 | 316 | 0.170 |
Why?
|
src Homology Domains | 1 | 2011 | 361 | 0.170 |
Why?
|
Sterols | 1 | 2009 | 63 | 0.170 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2010 | 99 | 0.170 |
Why?
|
Bile Ducts | 1 | 2010 | 282 | 0.170 |
Why?
|
Period Circadian Proteins | 1 | 2009 | 96 | 0.160 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2011 | 651 | 0.160 |
Why?
|
Liver | 4 | 2012 | 7531 | 0.160 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1809 | 0.160 |
Why?
|
Computational Biology | 2 | 2022 | 3512 | 0.160 |
Why?
|
Hepatitis B | 1 | 2014 | 707 | 0.160 |
Why?
|
Tissue Engineering | 1 | 2019 | 1872 | 0.160 |
Why?
|
Liver Transplantation | 1 | 2010 | 2333 | 0.160 |
Why?
|
Niclosamide | 1 | 2018 | 9 | 0.160 |
Why?
|
Th2 Cells | 1 | 2024 | 1058 | 0.160 |
Why?
|
Gene Silencing | 2 | 2012 | 1509 | 0.160 |
Why?
|
Hep G2 Cells | 3 | 2014 | 379 | 0.150 |
Why?
|
beta-Galactosidase | 1 | 2009 | 574 | 0.150 |
Why?
|
Hepatitis | 1 | 2010 | 229 | 0.150 |
Why?
|
Celastrus | 1 | 2007 | 1 | 0.150 |
Why?
|
Up-Regulation | 5 | 2019 | 4120 | 0.150 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2009 | 251 | 0.150 |
Why?
|
GTPase-Activating Proteins | 1 | 2010 | 471 | 0.150 |
Why?
|
Mice, Inbred BALB C | 6 | 2017 | 6210 | 0.150 |
Why?
|
Colorectal Neoplasms | 2 | 2017 | 6901 | 0.140 |
Why?
|
Plasmids | 1 | 2012 | 2275 | 0.140 |
Why?
|
Cadherins | 1 | 2012 | 904 | 0.140 |
Why?
|
Multilocus Sequence Typing | 2 | 2020 | 100 | 0.140 |
Why?
|
Umbilical Cord | 1 | 2018 | 179 | 0.140 |
Why?
|
Genes, p53 | 1 | 2009 | 712 | 0.140 |
Why?
|
Hepacivirus | 1 | 2014 | 1337 | 0.140 |
Why?
|
Interleukins | 1 | 2011 | 782 | 0.130 |
Why?
|
Humans | 49 | 2024 | 761326 | 0.130 |
Why?
|
Tretinoin | 1 | 2009 | 519 | 0.130 |
Why?
|
Surface Properties | 2 | 2020 | 1160 | 0.130 |
Why?
|
Niacinamide | 1 | 2018 | 413 | 0.130 |
Why?
|
Adipogenesis | 1 | 2018 | 368 | 0.130 |
Why?
|
Cartilage Diseases | 1 | 2007 | 157 | 0.130 |
Why?
|
Cell Death | 1 | 2011 | 1674 | 0.130 |
Why?
|
Esophageal Neoplasms | 1 | 2016 | 1647 | 0.130 |
Why?
|
Liver Cirrhosis | 2 | 2010 | 1934 | 0.130 |
Why?
|
Pneumonia | 1 | 2016 | 2140 | 0.120 |
Why?
|
Phenylurea Compounds | 1 | 2018 | 529 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2024 | 1158 | 0.120 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2011 | 832 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2009 | 2911 | 0.120 |
Why?
|
Escherichia coli | 2 | 2014 | 4234 | 0.120 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2010 | 1319 | 0.120 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2241 | 0.110 |
Why?
|
Synovial Membrane | 1 | 2007 | 532 | 0.110 |
Why?
|
DNA Primers | 2 | 2023 | 2820 | 0.110 |
Why?
|
Mice | 14 | 2024 | 81474 | 0.110 |
Why?
|
Viral Regulatory and Accessory Proteins | 2 | 2014 | 153 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2010 | 1612 | 0.110 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9414 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4567 | 0.110 |
Why?
|
Cell Line, Tumor | 6 | 2019 | 16966 | 0.110 |
Why?
|
HL-60 Cells | 3 | 2011 | 363 | 0.110 |
Why?
|
Animals | 17 | 2024 | 168388 | 0.100 |
Why?
|
Gene Expression Regulation | 4 | 2020 | 11900 | 0.100 |
Why?
|
Blotting, Western | 4 | 2010 | 5034 | 0.100 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13635 | 0.100 |
Why?
|
DNA Methylation | 2 | 2014 | 4383 | 0.100 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 119 | 0.090 |
Why?
|
Kinetics | 2 | 2019 | 6374 | 0.090 |
Why?
|
Venous Pressure | 1 | 2010 | 57 | 0.090 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5363 | 0.090 |
Why?
|
Signal Transduction | 4 | 2018 | 23427 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2804 | 0.090 |
Why?
|
Drug Synergism | 2 | 2018 | 1757 | 0.090 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3588 | 0.090 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11454 | 0.090 |
Why?
|
Adsorption | 1 | 2020 | 197 | 0.090 |
Why?
|
Genotype | 4 | 2020 | 12982 | 0.080 |
Why?
|
Flurbiprofen | 1 | 2019 | 21 | 0.080 |
Why?
|
Sirtuin 1 | 1 | 2021 | 245 | 0.080 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2019 | 100 | 0.080 |
Why?
|
Blood Volume | 1 | 2010 | 548 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2870 | 0.080 |
Why?
|
Male | 18 | 2024 | 360621 | 0.080 |
Why?
|
Liver Regeneration | 1 | 2010 | 213 | 0.080 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2021 | 237 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2008 | 6525 | 0.080 |
Why?
|
Hydrolysis | 1 | 2020 | 665 | 0.080 |
Why?
|
Nanofibers | 1 | 2019 | 66 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2010 | 3108 | 0.080 |
Why?
|
Doxycycline | 1 | 2021 | 344 | 0.080 |
Why?
|
In Situ Nick-End Labeling | 2 | 2010 | 609 | 0.080 |
Why?
|
Hospitals, University | 1 | 2020 | 564 | 0.080 |
Why?
|
NF-kappa B | 2 | 2017 | 2488 | 0.080 |
Why?
|
Esophageal and Gastric Varices | 1 | 2010 | 208 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6332 | 0.080 |
Why?
|
HCT116 Cells | 1 | 2019 | 402 | 0.080 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2018 | 43 | 0.080 |
Why?
|
Mice, Nude | 2 | 2018 | 3603 | 0.070 |
Why?
|
Female | 20 | 2024 | 392485 | 0.070 |
Why?
|
Calcium Phosphates | 1 | 2019 | 171 | 0.070 |
Why?
|
Portal Vein | 1 | 2010 | 431 | 0.070 |
Why?
|
Middle Aged | 13 | 2024 | 220774 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2019 | 507 | 0.070 |
Why?
|
Diet | 1 | 2016 | 8074 | 0.070 |
Why?
|
Myocytes, Cardiac | 2 | 2021 | 1671 | 0.070 |
Why?
|
Chitosan | 1 | 2019 | 131 | 0.070 |
Why?
|
Bacterial Adhesion | 1 | 2018 | 306 | 0.070 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 398 | 0.070 |
Why?
|
Gene Expression | 3 | 2019 | 7582 | 0.070 |
Why?
|
Thermodynamics | 1 | 2018 | 595 | 0.070 |
Why?
|
Fibroblasts | 2 | 2018 | 4139 | 0.070 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 437 | 0.070 |
Why?
|
Blood Flow Velocity | 1 | 2010 | 1370 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2018 | 6231 | 0.070 |
Why?
|
Adenosine | 1 | 2021 | 805 | 0.070 |
Why?
|
Peptides | 1 | 2008 | 4342 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3202 | 0.070 |
Why?
|
Quinoxalines | 1 | 2018 | 296 | 0.070 |
Why?
|
Osteoclasts | 1 | 2020 | 711 | 0.070 |
Why?
|
Cell Movement | 2 | 2018 | 5202 | 0.070 |
Why?
|
Bone Regeneration | 1 | 2019 | 432 | 0.070 |
Why?
|
RNA, Messenger | 4 | 2014 | 12787 | 0.060 |
Why?
|
Vancomycin | 1 | 2019 | 503 | 0.060 |
Why?
|
Genetic Vectors | 3 | 2018 | 3393 | 0.060 |
Why?
|
Base Sequence | 2 | 2019 | 12449 | 0.060 |
Why?
|
Thiazolidinediones | 1 | 2018 | 461 | 0.060 |
Why?
|
Delayed-Action Preparations | 1 | 2019 | 962 | 0.060 |
Why?
|
Angiography | 1 | 2010 | 1599 | 0.060 |
Why?
|
Calcium-Binding Proteins | 1 | 2020 | 1069 | 0.060 |
Why?
|
Cell Line | 3 | 2019 | 15599 | 0.060 |
Why?
|
Enzyme Activation | 2 | 2011 | 3592 | 0.060 |
Why?
|
Drug Combinations | 1 | 2021 | 2048 | 0.060 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2014 | 143 | 0.060 |
Why?
|
Spleen | 1 | 2010 | 2296 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2020 | 22124 | 0.060 |
Why?
|
Osteoblasts | 1 | 2020 | 1143 | 0.060 |
Why?
|
Protein Transport | 2 | 2011 | 1967 | 0.060 |
Why?
|
Deoxycytidine | 1 | 2018 | 875 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2498 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 614 | 0.060 |
Why?
|
Tumor Stem Cell Assay | 1 | 2014 | 115 | 0.060 |
Why?
|
Adult | 10 | 2024 | 221122 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3806 | 0.060 |
Why?
|
Lymphatic Metastasis | 1 | 2022 | 2914 | 0.060 |
Why?
|
Stress, Mechanical | 1 | 2019 | 1674 | 0.060 |
Why?
|
Mammals | 1 | 2019 | 1132 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2024 | 18962 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 687 | 0.060 |
Why?
|
Phosphorylation | 2 | 2018 | 8312 | 0.060 |
Why?
|
Risk Factors | 5 | 2021 | 74152 | 0.050 |
Why?
|
Aged | 8 | 2024 | 169179 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 3161 | 0.050 |
Why?
|
Phylogeny | 1 | 2020 | 2809 | 0.050 |
Why?
|
Enzyme Assays | 1 | 2013 | 104 | 0.050 |
Why?
|
Autophagy | 1 | 2021 | 1321 | 0.050 |
Why?
|
Microscopy, Confocal | 2 | 2009 | 1968 | 0.050 |
Why?
|
Neoplasms | 1 | 2022 | 22158 | 0.050 |
Why?
|
Intracellular Space | 1 | 2013 | 197 | 0.050 |
Why?
|
S Phase | 1 | 2014 | 421 | 0.050 |
Why?
|
G1 Phase | 1 | 2014 | 403 | 0.050 |
Why?
|
Amplified Fragment Length Polymorphism Analysis | 1 | 2012 | 10 | 0.050 |
Why?
|
Fluoroquinolones | 1 | 2014 | 308 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15879 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2019 | 3089 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2010 | 11070 | 0.050 |
Why?
|
Pancreas | 1 | 2018 | 1689 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 1 | 2007 | 3760 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 4246 | 0.050 |
Why?
|
DNA Modification Methylases | 1 | 2012 | 210 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58946 | 0.050 |
Why?
|
Cytokines | 2 | 2024 | 7390 | 0.050 |
Why?
|
Gene Order | 1 | 2011 | 169 | 0.050 |
Why?
|
RNA, Antisense | 1 | 2011 | 136 | 0.050 |
Why?
|
Prevalence | 2 | 2020 | 15719 | 0.040 |
Why?
|
Biocompatible Materials | 1 | 2019 | 1689 | 0.040 |
Why?
|
Endoscopy | 1 | 2010 | 1851 | 0.040 |
Why?
|
Azacitidine | 1 | 2012 | 336 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3590 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2018 | 18234 | 0.040 |
Why?
|
Caspase 1 | 1 | 2021 | 226 | 0.040 |
Why?
|
Protein Binding | 2 | 2013 | 9351 | 0.040 |
Why?
|
bcl-2-Associated X Protein | 1 | 2011 | 282 | 0.040 |
Why?
|
Cyclin B1 | 1 | 2009 | 58 | 0.040 |
Why?
|
Colony-Forming Units Assay | 1 | 2010 | 352 | 0.040 |
Why?
|
Mesylates | 1 | 2009 | 37 | 0.040 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1486 | 0.040 |
Why?
|
Oxidants | 1 | 2010 | 169 | 0.040 |
Why?
|
Cytoprotection | 1 | 2010 | 200 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 17640 | 0.040 |
Why?
|
Infarction | 1 | 2021 | 248 | 0.040 |
Why?
|
DNA Fragmentation | 1 | 2009 | 237 | 0.040 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 283 | 0.040 |
Why?
|
Peptide Mapping | 1 | 2009 | 262 | 0.040 |
Why?
|
Phenotype | 2 | 2019 | 16603 | 0.040 |
Why?
|
Transposon Resolvases | 1 | 2018 | 1 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2009 | 130 | 0.040 |
Why?
|
Sputum | 1 | 2011 | 506 | 0.040 |
Why?
|
Inpatients | 1 | 2020 | 2548 | 0.040 |
Why?
|
Protein Stability | 1 | 2010 | 578 | 0.040 |
Why?
|
Flow Cytometry | 2 | 2009 | 5866 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2011 | 468 | 0.040 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2009 | 176 | 0.040 |
Why?
|
Protein Sorting Signals | 1 | 2009 | 279 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2011 | 605 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2011 | 3792 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2010 | 522 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2009 | 427 | 0.040 |
Why?
|
Bone and Bones | 1 | 2019 | 2568 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2010 | 931 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 641 | 0.040 |
Why?
|
Caspases | 1 | 2011 | 877 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 868 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3793 | 0.040 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2018 | 257 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2018 | 1726 | 0.040 |
Why?
|
Granulocytes | 1 | 2009 | 552 | 0.040 |
Why?
|
CpG Islands | 1 | 2012 | 1225 | 0.040 |
Why?
|
Immunoassay | 1 | 2011 | 746 | 0.040 |
Why?
|
Nanoparticles | 1 | 2019 | 1955 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12450 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2020 | 3744 | 0.030 |
Why?
|
Chondrogenesis | 1 | 2018 | 239 | 0.030 |
Why?
|
Prognosis | 2 | 2022 | 29588 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2010 | 728 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2010 | 1494 | 0.030 |
Why?
|
Public Health | 1 | 2019 | 2667 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2468 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2012 | 2712 | 0.030 |
Why?
|
Necrosis | 1 | 2010 | 1605 | 0.030 |
Why?
|
Tubulin | 1 | 2009 | 693 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2022 | 15262 | 0.030 |
Why?
|
Cell Transplantation | 1 | 2007 | 472 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2009 | 2265 | 0.030 |
Why?
|
Gene Frequency | 1 | 2012 | 3639 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 1405 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14665 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2009 | 988 | 0.030 |
Why?
|
Steroids | 1 | 2009 | 928 | 0.030 |
Why?
|
Cell Separation | 1 | 2009 | 1722 | 0.030 |
Why?
|
Hyperplasia | 1 | 2007 | 1153 | 0.030 |
Why?
|
Risk | 1 | 2016 | 9605 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2018 | 5297 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2018 | 1170 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 2062 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2008 | 4175 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1742 | 0.030 |
Why?
|
Hepatocytes | 1 | 2010 | 1232 | 0.030 |
Why?
|
Mutation | 2 | 2023 | 30044 | 0.030 |
Why?
|
Kidney | 1 | 2018 | 7049 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2724 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1114 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5665 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2011 | 2453 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5670 | 0.020 |
Why?
|
Binding Sites | 1 | 2011 | 6052 | 0.020 |
Why?
|
Young Adult | 3 | 2024 | 59196 | 0.020 |
Why?
|
Alleles | 1 | 2012 | 6909 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6086 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4740 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1669 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5778 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2009 | 2909 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3075 | 0.020 |
Why?
|
Adolescent | 3 | 2024 | 88305 | 0.020 |
Why?
|
Monocytes | 1 | 2009 | 2573 | 0.020 |
Why?
|
Histones | 1 | 2010 | 2579 | 0.020 |
Why?
|
Odds Ratio | 1 | 2012 | 9639 | 0.020 |
Why?
|
Proteome | 1 | 2009 | 1863 | 0.020 |
Why?
|
Smoking | 1 | 2016 | 9051 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13446 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2897 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20092 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22154 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2011 | 901 | 0.020 |
Why?
|
Lung | 1 | 2016 | 9994 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2009 | 2223 | 0.020 |
Why?
|
Infant | 1 | 2020 | 36202 | 0.020 |
Why?
|
Chromatin | 1 | 2009 | 2960 | 0.020 |
Why?
|
DNA | 1 | 2011 | 7216 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3448 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3611 | 0.020 |
Why?
|
Prospective Studies | 1 | 2020 | 54405 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4355 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3572 | 0.020 |
Why?
|
Models, Biological | 1 | 2011 | 9468 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23729 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2009 | 5794 | 0.010 |
Why?
|
Cell Division | 1 | 2011 | 4466 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 41440 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 17872 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 39974 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26211 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2015 | 80575 | 0.010 |
Why?
|
Child | 1 | 2011 | 80156 | 0.010 |
Why?
|